Last 30 days
-8.5%
Last 90 days
-23.6%
Trailing 12 Months
-50.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 407.3B | 94.9B | 1.59% | -10.18% | 22.7 | 4.29 | 1.25% | -14.07% |
LLY | 309.3B | 28.5B | 9.31% | 21.06% | 49.53 | 10.84 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | 0.45% | 33.58% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 228.8B | 100.3B | 1.54% | -19.24% | 7.29 | 2.28 | 23.43% | 42.74% |
BMY | 147.4B | 46.2B | -0.07% | -3.71% | 23.29 | 3.19 | -0.49% | -9.54% |
MID-CAP | ||||||||
PRGO | 4.8B | 4.5B | -5.43% | -6.05% | -34.34 | 1.08 | 7.56% | -104.06% |
RETA | 3.3B | 2.2M | -2.41% | 177.53% | -10.65 | 1.5K | -80.71% | -4.88% |
SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -7.69% | 12.10% | 31.78 | 2.89 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -7.75% | -62.41% | -2.73 | 2.62 | 18.18% | -18.59% |
CGC | 850.7M | 478.9M | -22.22% | -76.91% | -0.27 | 1.78 | -31.50% | -634.70% |
INVA | 778.4M | 285.2M | -1.06% | -41.86% | 3.53 | 2.73 | -27.21% | -40.28% |
CRON | 738.3M | 114.5M | -8.49% | -50.13% | -4.38 | 6.45 | 27.90% | 57.40% |
ACRS | 539.5M | 29.8M | -33.91% | -53.07% | -6.21 | 18.13 | 340.05% | 4.35% |
OCUL | 406.9M | 51.5M | -13.18% | 6.46% | -5.73 | 7.9 | 18.32% | -984.05% |
ENDP | 94.1M | 2.3B | -43.99% | -88.43% | -0.03 | 0.04 | -22.53% | -376.66% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -1.3% | 114,456,000 | 115,938,000 | 113,944,000 | 104,238,000 | 89,486,000 |
Gross Profit | -15.4% | 11,969,000 | 14,146,000 | 12,259,000 | -7,645,000 | -17,534,000 |
Operating Expenses | -49.7% | 136,807,000 | 271,900,000 | 295,423,000 | 543,798,000 | 543,060,000 |
S&GA Expenses | -18.0% | 22,282,000 | 27,170,000 | 32,068,000 | 39,695,000 | 44,937,000 |
R&D Expenses | -23.4% | 13,381,000 | 17,467,000 | 21,371,000 | 22,268,000 | 23,331,000 |
EBITDA | 40.5% | -128,534,000 | -215,997,000 | -104,266,000 | -262,753,000 | - |
EBITDA Margin | 39.7% | -1.12 | -1.86 | -0.69 | -1.28 | - |
Earnings Before Taxes | 39.4% | -134,559,000 | -221,869,000 | -109,676,000 | -267,822,000 | -397,135,000 |
EBT Margin | 38.6% | -1.18 | -1.91 | -0.73 | -1.30 | - |
Interest Expenses | NaN% | 0.00 | 0.00 | 0.00 | - | - |
Net Income | 24.5% | -168,734,000 | -223,619,000 | -108,712,000 | -267,727,000 | -396,107,000 |
Net Income Margin | 23.6% | -1.47 | -1.93 | -0.72 | -1.30 | - |
Free Cahsflow | 11.2% | -92,399,000 | -104,094,000 | -123,625,000 | -146,700,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -2.0% | 1,213 | 1,237 | 1,332 | 1,371 | 1,398 |
Current Assets | -0.3% | 960 | 963 | 1,026 | 1,063 | 1,080 |
Cash Equivalents | 20.7% | 765 | 633 | 790 | 862 | 887 |
Inventory | 10.2% | 38.00 | 34.00 | 40.00 | 37.00 | 33.00 |
Net PPE | 0.0% | 61.00 | 61.00 | 66.00 | 72.00 | 74.00 |
Goodwill | 2.1% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 55.9% | 72.00 | 46.00 | 47.00 | 50.00 | 63.00 |
Current Liabilities | 79.4% | 68.00 | 38.00 | 39.00 | 40.00 | 54.00 |
Shareholder's Equity | -4.2% | 1,144 | 1,194 | 1,285 | 1,321 | 1,337 |
Retained Earnings | -13.8% | 491 | 570 | 607 | 627 | 659 |
Additional Paid-In Capital | 11.4% | 43.00 | 38.00 | 35.00 | 35.00 | 32.00 |
Accumulated Depreciation | - | 30.00 | - | - | - | - |
Shares Outstanding | 0.6% | 381 | 378 | 378 | 375 | 375 |
Minority Interest | -0.6% | -2.92 | -2.90 | -3.11 | -3.23 | -2.97 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 11.5% | -88.95 | -100 | -118 | -140 | -153 |
Share Based Compensation | -27.0% | 15.00 | 21.00 | 19.00 | 19.00 | 18.00 |
Cashflow From Investing | 97.7% | -1.84 | -78.96 | 37.00 | -19.08 | -28.90 |
Cashflow From Financing | -13.4% | -2.90 | -2.56 | -6.57 | -5.24 | -13.44 |
100%
96.5%
82.3%
Y-axis is the maximum loss one would have experienced if Cronos Group was unfortunately bought at previous high price.
-22.0%
-30.1%
FIve years rolling returns for Cronos Group.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | ETF MANAGERS GROUP, LLC | sold off | -100 | -26,126,000 | - | -% |
2023-03-17 | American Portfolios Advisors | reduced | -0.5 | -282 | 55,768 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 0.05 | -1,000 | 9,000 | -% |
2023-03-06 | OLD MISSION CAPITAL LLC | new | - | 34,734 | 34,734 | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | unchanged | - | -465 | 6,535 | -% |
2023-02-27 | Parallax Volatility Advisers, L.P. | reduced | -19.49 | -79,298 | 209,702 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | reduced | -98.68 | -12,848 | 152 | -% |
2023-02-24 | NATIXIS | new | - | 13,462 | 13,462 | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -1.38 | -452 | 2,548 | -% |
2023-02-17 | Coppell Advisory Solutions Corp. | new | - | 254 | 254 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Dec 19, 2022 | altria group, inc. | 41% | 156,573,537 | SC 13D/A | |
Feb 12, 2020 | chesapeake partners management co inc/md | 2.58% | 8,873,890 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 1.13 -41.75% | 1.15 -40.72% | 1.29 -33.51% | 1.62 -16.49% | 1.78 -8.25% |
Current Inflation | 1.12 -42.27% | 1.13 -41.75% | 1.27 -34.54% | 1.57 -19.07% | 1.72 -11.34% |
Very High Inflation | 1.10 -43.30% | 1.12 -42.27% | 1.24 -36.08% | 1.50 -22.68% | 1.64 -15.46% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-15 | Buggy Shannon | sold (taxes) | -10,262 | 1.99 | -5,157 | svp, global head of people |
2023-03-15 | Buggy Shannon | acquired | - | - | 13,889 | svp, global head of people |
2023-03-15 | Cortez Carlos S. | sold (taxes) | -8,111 | 1.99 | -4,076 | vp, controller |
2023-03-15 | JACOBSON JEFFREY DAVID | sold (taxes) | -45,519 | 2.72 | -16,735 | chief growth officer |
2023-03-15 | Cortez Carlos S. | acquired | - | - | 13,750 | vp, controller |
2023-03-15 | GORENSTEIN MICHAEL RYAN | acquired | - | - | 31,361 | see remarks below |
2023-03-15 | GORENSTEIN MICHAEL RYAN | sold (taxes) | -15,195 | 1.99 | -7,636 | see remarks below |
2023-03-15 | Shlimak Anna | sold (taxes) | -17,701 | 1.99 | -8,895 | see remarks |
2023-03-15 | Shlimak Anna | acquired | - | - | 30,000 | see remarks |
2023-03-15 | JACOBSON JEFFREY DAVID | acquired | - | - | 31,767 | chief growth officer |
Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net revenue, before excise taxes | $ 114,456,000 | $ 89,486,000 | $ 54,353,000 |
Excise taxes | (22,552,000) | (15,051,000) | (7,634,000) |
Net revenue | 91,904,000 | 74,435,000 | 46,719,000 |
Cost of sales | 79,935,000 | 80,008,000 | 46,497,000 |
Inventory write-down | 0 | 11,961,000 | 26,055,000 |
Gross profit | 11,969,000 | (17,534,000) | (25,833,000) |
Operating expenses | |||
Sales and marketing | 22,282,000 | 44,937,000 | 34,386,000 |
Research and development | 13,381,000 | 23,331,000 | 20,366,000 |
General and administrative | 71,178,000 | 96,482,000 | 80,569,000 |
Restructuring costs | 5,333,000 | 0 | 0 |
Share-based compensation | 15,115,000 | 10,151,000 | 15,361,000 |
Depreciation and amortization | 6,025,000 | 4,484,000 | 2,872,000 |
Impairment loss on goodwill and indefinite-lived intangible assets | 0 | 236,056,000 | 40,000,000 |
Impairment loss on long-lived assets | 3,493,000 | 127,619,000 | 0 |
Total operating expenses | 136,807,000 | 543,060,000 | 193,554,000 |
Operating loss | (124,838,000) | (560,594,000) | (219,387,000) |
Other income (expense) | |||
Interest income, net | 22,537,000 | 9,071,000 | 18,415,000 |
Gain on revaluation of derivative liabilities | 14,060,000 | 151,360,000 | 129,254,000 |
Share of income (loss) from equity method investments | 3,114,000 | (6,313,000) | (4,510,000) |
Gain (loss) on revaluation of financial instruments | 14,739,000 | 8,611,000 | (9,000) |
Impairment loss on other investments | (61,392,000) | 0 | 0 |
Foreign currency transaction loss | (2,286,000) | 0 | 0 |
Gain on disposal of investments | 0 | 0 | 4,789,000 |
Other, net | (493,000) | 730,000 | (1,825,000) |
Total other income (expense) | (9,721,000) | 163,459,000 | 146,114,000 |
Loss before income taxes | (134,559,000) | (397,135,000) | (73,273,000) |
Income tax expense (benefit) | 34,175,000 | (431,000) | 1,347,000 |
Loss from continuing operations | (168,734,000) | (396,704,000) | (74,620,000) |
Loss from discontinued operations | 0 | (500,000) | (650,000) |
Net loss | (168,734,000) | (397,204,000) | (75,270,000) |
Net loss attributable to non-controlling interest | 0 | (1,097,000) | (2,133,000) |
Net loss attributable to Cronos Group | (168,734,000) | (396,107,000) | (73,137,000) |
Comprehensive income (loss) | |||
Net loss | (168,734,000) | (397,204,000) | (75,270,000) |
Foreign exchange gain (loss) on translation | (50,616,000) | 8,192,000 | 14,951,000 |
Comprehensive loss | (219,350,000) | (389,012,000) | (60,319,000) |
Comprehensive income (loss) attributable to non-controlling interest | 46,000 | 229,000 | (2,343,000) |
Comprehensive loss attributable to Cronos Group | $ (219,396,000) | $ (389,241,000) | $ (57,976,000) |
Net loss from continuing operations per share | |||
Basic (in dollars per share) | $ (0.45) | $ (1.07) | $ (0.21) |
Diluted (in dollars per share) | $ (0.45) | $ (1.07) | $ (0.21) |
Consolidated Balance Sheet - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 764,644 | $ 886,973 |
Short-term investments | 113,077 | 117,684 |
Accounts receivable, net | 23,113 | 22,067 |
Other receivables | 5,767 | 5,765 |
Current portion of loans receivable, net | 8,890 | 5,460 |
Inventory, net | 37,559 | 32,802 |
Prepaids and other current assets | 7,106 | 8,967 |
Total current assets | 960,156 | 1,079,718 |
Equity method investments, net | 18,755 | 16,764 |
Other investments | 70,993 | 118,392 |
Non-current portion of loans receivable, net | 72,345 | 80,635 |
Property, plant and equipment, net | 60,557 | 74,070 |
Right-of-use assets | 2,273 | 8,882 |
Goodwill | 1,033 | 1,098 |
Intangible assets, net | 26,704 | 18,079 |
Other | 193 | 100 |
Total assets | 1,213,009 | 1,397,738 |
Current liabilities | ||
Accounts payable | 11,163 | 11,113 |
Income taxes payable | 32,956 | 105 |
Accrued liabilities | 22,268 | 25,636 |
Current portion of lease obligation | 1,330 | 2,711 |
Derivative liabilities | 15 | 14,375 |
Current portion due to non-controlling interests | 384 | 433 |
Total current liabilities | 68,116 | 54,373 |
Non-current portion due to non-controlling interests | 1,383 | 1,913 |
Non-current portion of lease obligation | 2,546 | 7,095 |
Deferred income tax liability | 0 | 81 |
Total liabilities | 72,045 | 63,462 |
Shareholders’ equity | ||
Share capital (authorized for issue as of December 31, 2022 and 2021: unlimited; shares outstanding as of December 31, 2022 and 2021: 380,575,403 and 374,952,693, respectively) | 611,318 | 595,497 |
Additional paid-in capital | 42,682 | 32,465 |
Retained earnings | 490,682 | 659,416 |
Accumulated other comprehensive income (loss) | (797) | 49,865 |
Total equity attributable to shareholders of Cronos Group | 1,143,885 | 1,337,243 |
Non-controlling interests | (2,921) | (2,967) |
Total shareholders’ equity | 1,140,964 | 1,334,276 |
Total liabilities and shareholders’ equity | $ 1,213,009 | $ 1,397,738 |